Drug Type Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms P30-linked EphA2, CMV pp65, and survivin vaccination(Duke University) + [1] |
Mechanism CMV pp65 modulators(Cytomegalovirus pp65 Antigen modulators), EphA2 antagonists(Ephrin type-A receptor 2 antagonists), survivin inhibitors(Baculoviral IAP repeat-containing protein 5 inhibitors) + [1] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma Multiforme | Phase 1 | US | 30 Aug 2023 |